a group of 16 patients with secondary chronic progression of multiple sclerosis treated by short-lasting intensive immunosuppression ( cyclophosphamide with acth ) by the programme of hausser et al ( 4 ) was compared with a clinically similar group of 16 patients treated exclusively with intramuscular acth .
C0026769
multiple sclerosis
C0010583
cyclophosphamide